Are Time-Outs Harmful to Kids? The Latest Research Says Otherwise

0
38

When Amy and Steve Unruh decided to adopt a four-year-old child from the Philippines, they anticipated challenges. They understood it would take time, as well as a great deal of love and care, for their family and its newest member to adjust. But they were committed to helping a child in need.
The Unruh’s were blindsided when their adoption application was turned down. The reason, they were told, was that their parenting style was not suitable for an adopted child. “They said it was because we’ve used time-outs with our daughter,” says Amy Unruh, 43, who is a stay-at-home mom in Milton, Florida. During her interview with the adoption agency, she’d explained that, when her biological daughter misbehaves and doesn’t respond to verbal warnings, she is occasionally sent to her room or told to sit quietly in a chair for five minutes. “They told us this was isolating and not appropriate for an adopted child—or for any child,” Unruh says. “We were devastated.”

Both the American Academy of Pediatrics and the American Academy of Child and Adolescent Psychiatry promote time-outs as an effective parenting strategy. Among kids with oppositional defiant disorder or attention deficit/hyperactivity disorder—the two most commonly diagnosed causes of disruptive behavior in children—research has found that time-outs can help correct problem behaviors.
But recently, some prominent child psychologists have raised doub…

Source: TIME: HealthCategory: Consumer Health News Authors: Tags: Uncategorized Parenting Source Type: news

Related Links:

Discussion
Fragile X syndrome (FXS) was first clinically described in 1943 by Martin-Bell and in 1969 Lubs found a fragility at the terminal end of the X chromosome. In 1991, three different research groups independently cloned the mutation for the FMR1 gene (Fragile X mental retardation type 1) which has a CGG triplet expansion. The FMR1 gene codes for the FMR protein which is a major regulator of synaptic plasticity and is expressed in the brain and spermatogonia mainly but many other tissues during fetal and early neonatal development. The number of triplets and methylation correlates with clinical expression (increased…

Source: PediatricEducation.orgCategory: Pediatrics Authors: Tags: Uncategorized Source Type: news

Women who have endometriosis have a higher risk of mental illnesses such as depression, anxiety, and substance use disorders (SUDs), suggests astudy in theAmerican Journal of Obstetrics and Gynecology. The study also revealed that the opposite may be true: Women who have depression, anxiety, or other mental illnesses may have a higher risk of endometriosis. Endometriosis is an often painful condition that occurs when tissue similar to the lining of the uterus, called the endometrium, grows in other places, such as the fallopian tubes and ovaries.Menghan Gao, M.Sc., of the Karolinksa Institute in Stockholm and colleagues an…

Source: Psychiatr NewsCategory: Psychiatry Tags: ADHD American Journal of Obstetrics and Gynecology anxiety depression eating disorders endometriosis Menghan Gao personality disorders substance use disorders women Source Type: research

CASE:
Thomas is a 13-year-old boy with autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), generalized anxiety disorder, separation anxiety disorder, and major depressive disorder who presented for a follow-up to his developmental and behavioral pediatrician (DBP). His mother describes an increase in symptoms of anxiety and depression for the last 6 weeks, accompanied by suicidal ideation and thoughts of self-mutilation.
Before this increase in symptoms, he had been doing well for the last several months with the exception of increasing weight gain, and Abilify was decreased from 5 mg to 2.5 mg at…

While recreational marijuana is legal in 11 states as of November 2019, more states gravitating toward legalizing the recreational use of the substance, and 33 states allowing medical marijuana, there’s apparently no stopping this trend. Cannabis, in the form of marijuana, hemp, and cannabidiol (CBD)  is being used for pain relief, to alleviate stress, cope with anxiety, and a number of other mental health disorders and addictions.
Yet, there’s a dearth of clinical studies that have been conducted on the overall effects on a user’s health. Clearly, as Crain’s Detroit Business points out, more …

Source: World of PsychologyCategory: Psychiatry & Psychology Authors: Tags: Medications Substance Abuse Cannabis Marijuana Source Type: blogs

There is little evidence that the use of cannabinoids can improve symptoms of anxiety, attention-deficit/hyperactivity disorder (ADHD), depression, posttraumatic stress disorder (PTSD), psychosis, or Tourette syndrome, according to areport inLancet Psychiatry.“Cannabinoids are often advocated as a treatment for various mental disorders,” wrote Nicola Black, Ph.D., of the University of New South Wales and colleagues. Doctors and patients “need to be aware of the low quality and quantity of evidence for the effectiveness of medicinal cannabinoids in treating mental disorders and the potential risk of advers…

Source: Psychiatr NewsCategory: Psychiatry Tags: ADHD anxiety cannabinoids cannabis Deepak Cyril D ’Souza depression meta-analysis Nicola Black psychiatric disorders PTSD Tourette syndrome Source Type: research

This study is registered with PROSPERO (CRD42017059372, CRD42017059373, CRD42017059376, CRD42017064996, and CRD42018102977).Findings83 eligible studies (40 randomised controlled trials, n=3067) were included: 42 for depression (23 randomised controlled trials; n=2551), 31 for anxiety (17 randomised controlled trials; n=605), eight for Tourette syndrome (two randomised controlled trials; n=36), three for ADHD (one randomised controlled trial; n=30), 12 for post-traumatic stress disorder (one randomised controlled trial; n=10), and 11 for psychosis (six randomised controlled trials; n=281). Pharmaceutical THC (with or withou…

Rui Yan1, ShiWan Tao1, HaiYan Liu1, Yu Chen1, JiaBo Shi1, YuYin Yang1, RongXin Zhu1, ZhiJian Yao1,2* and Qing Lu3,4*1Department of Psychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China2Nanjing Brain Hospital, Medical School of Nanjing University, Nanjing, China3School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, China4Child Development and Learning Science, Key Laboratory of Ministry of Education, Nanjing, ChinaBackground: Major depressive disorders often involve somatic symptoms and have been found to have fundamental differences from non-somatic depressi…

In conclusion, our data show some of the brain modifications probably responsible for the behavioral phenotype associated with TBI and suggest the CBD as a pharmacological tool to improve neurological dysfunctions caused by the trauma.



Introduction
The phytocannabinoid cannabidiol (CBD), the major non-psychoactive constituent of Cannabis sativa, exhibits a broad spectrum of potential therapeutic properties, including neuroprotective effects in Central Nervous System (CNS) disorders (Fernández-Ruiz et al., 2013; De Gregorio et al., 2018; Schonhofen et al., 2018). Through a multitarget mechanism, CBD shows pot…



Nicola Cellini1,2, Renee E. Shimizu3, Patrick M. Connolly3, Diana M. Armstrong4, Lexus T. Hernandez2, Anthony G. Polakiewicz3, Rolando Estrada3†, Mario Aguilar-Simon3, Michael P. Weisend4†, Sara C. Mednick2 and Stephen B. Simons3*

1Department of General Psychology, University of Padova, Padova, Italy
2Department of Cognitive Science, University of California, Irvine, Irvine, CA, United States
3Teledyne Scientific &Imaging, Durham, NC, United States
4Rio Grande Neurosciences, Dayton, OH, United States

Transcranial electrical stimulation (tES) during sleep has been shown to successfully modula…

In conclusion, the studies presented in the current review demonstrate that CBD has the potential to limit delta-9-THC-induced cognitive impairment and improve cognitive function in various pathological conditions.
Human studies suggest that CBD may have a protective role in delta-9-THC-induced cognitive impairments; however, there is limited human evidence for CBD treatment effects in pathological states (e.g. schizophrenia).
In short, they found that CBD may help alleviate the negative impact of a person with schizophrenia from taking cannabis, both in the psychotic and cognitive symptoms associated with schizophrenia. T…

Source: World of PsychologyCategory: Psychiatry & Psychology Authors: Tags: Alternative and Nutritional Supplements Disorders General Research Treatment cannabidiol Cannabis cbd cbd oil Marijuana THC Source Type: blogs

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here